NDC 0409-0528-13 - LEVOFLOXACIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-0528
- Requested NDC
- 0409-0528-13
- Package NDCs from labels
- 0409-0528-13, 0409-0528-15, 0409-0528-23, 0409-0528-25, 0409-0528-31, 0409-0528-35
- Manufacturer
- Hospira, Inc.
- Effective date
- 2024-07-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEVOFLOXACIN - Hospira, Inc. | Hospira, Inc. | 2024-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-0528-13 | ML - Milliliter | 0409-0528 | 013298df-7b8b-4f7f-b569-f242723b8f92 | 1 | 2017-05-03 |
| 0409-0528-15 | ML - Milliliter | 0409-0528 | 97f8a2ab-60be-400d-a5ee-87ec35a15882 | 1 | 2017-05-03 |
| 0409-0528-23 | ML - Milliliter | 0409-0528 | 97b3e06a-c996-4acd-9c5d-a65daa28484c | 1 | 2017-05-03 |
| 0409-0528-25 | ML - Milliliter | 0409-0528 | d0ae828a-16ed-4696-a35c-efff56be261c | 1 | 2017-05-03 |
| 0409-0528-31 | ML - Milliliter | 0409-0528 | 3a48fd93-1a4e-46a6-b05c-e1aff56a85c1 | 1 | 2017-05-03 |
| 0409-0528-35 | ML - Milliliter | 0409-0528 | 7b0182fe-f9ed-4be4-84a6-99727eea713e | 1 | 2017-05-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVOFLOXACIN | ACTIVE INGREDIENT | 6GNT3Y5LMF | LEVOFLOXACIN INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| LEVOFLOXACIN ANHYDROUS | ACTIVE MOIETY | RIX4E89Y14 | LEVOFLOXACIN INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | LEVOFLOXACIN INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LEVOFLOXACIN INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LEVOFLOXACIN INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | LX22YL083G | |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | LX22YL083G |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | LX22YL083G |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | LX22YL083G |
| levofloxacin | LEVOFLOXACIN | Redpharm Drug | 5261da15-1b6c-fbe2-e063-6394a90ad85e | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | Cardinal Health 107, LLC | 070375be-3b67-4299-ae8f-4a7b157ac16f | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| Levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals, Inc. | bcad1dad-53aa-43dd-90f3-cc17cc9598d5 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals, Inc. | 2a8676a9-247f-4fdb-b644-e9785d98771f | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Dextrose | DEXTROSE | B. Braun Medical Inc. | 60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5 | 2026-05-12 | Warnings, Adverse reactions | LX22YL083G |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | LX22YL083G |
| LEVOFLOXACIN | LEVOFLOXACIN | DIRECT RX | 4f40d5fa-ebcc-516c-e054-00144ff8d46c | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| 85c2b481-ae89-4a15-aa6a-ed390a9f0d85 | 17bcb105-91ff-4240-bba4-29d80001bbe4 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 17bcb105-91ff-4240-bba4-29d80001bbe4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.